Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort-Reference-Cited by-同舟云学术

Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort

Published:2021-01 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Malespin Miguel H.,Barritt Alfred Sidney,Watkins Stephanie E.^ORCID,Schoen Cheryl,Tincopa Monica A.,Corbin Karen D.,Mospan Andrea R.,Munoz Breda,Trinh Huy N.,Weiss L. Michael,Reddy K. Rajender,Loomba Rohit,Kemmer Nyingi,Lok Anna S.^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference9 articles.

1. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

2. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalsani;Hepatology,2018

3. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis;Vilar-Gomez;Gastroenterology,2015

4. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: the TARGET-NASH study;Barritt;Contemp Clin Trials,2017

5. Elevated metabolic rates in obesity;James;Lancet,1978

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

2. Endoscopic sleeve gastroplasty for metabolic dysfunction-associated steatotic liver disease;Expert Review of Gastroenterology & Hepatology;2024-08-02

3. Update on Newly Federal Drug Administration-Approved Drug, Resmetirom: A Practical Perspective;American Journal of Gastroenterology;2024-06-28

4. Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach;European Cardiology Review;2024-06-19

5. The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients;Life;2024-05-27